In The News

HepQuant and our liver disease experts have been featured in numerous news interviews and medical publications in recent years. The following is a partial list of news stories and articles in which we have been involved:

2021

• April 14 – HepQuant’s Greg Everson, MD, to Speak at AASLD/FDA Conference on Drug-Induced Liver Injury (DILI)

2019

• 4/4/19 Intercept to Present Results from the First Successful Phase 3 Trial in Patients with Liver Fibrosis Due to NASH at the International Liver Congress™ 2019

2018

• 7/31/18 Hep C Expert Interview: Gregory T. Everson, MD (PatientCareOnline – ModernMedicine Network) | PDF Download

2017

• Dec 2017  Greg Everson Retires After Pioneering Career | PDF Download
• 6/22/17 History of a Cure

2016

• 2/11/16 Developing Tests to Assess Liver Function in NASH and Cirrhosis (Galectin Therapeutics CEO Perspectives)
• 2/11/16 Colorado OEDIT Grants $4.6M to Colorado Organizations (Colorado Bioscience Association)

2014-2015 Archive